Live Oak Health Sciences holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Live Oak Health Sciences Fund LOGSX
- NAV / 1-Day Return 25.67 / −0.23 %
- Total Assets 61.2M
-
Adj. Expense Ratio
1.040%
- Expense Ratio 1.040%
- Distribution Fee Level Above Average
- Share Class Type Institutional
- Category Health
- Investment Style Mid Value
- Min. Initial Investment 2,000
- Status Open
- TTM Yield 0.09%
- Turnover 24%
USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 12:55 AM GMT+0
Morningstar’s Analysis LOGSX
Will LOGSX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 51.4
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Cardinal Health Inc | 6.45 | 3M | Healthcare |
Jazz Pharmaceuticals PLC | 5.86 | 3M | Healthcare |
United Therapeutics Corp | 5.71 | 3M | Healthcare |
Lantheus Holdings Inc | 5.55 | 3M | Healthcare |
Exelixis Inc | 5.42 | 3M | Healthcare |
Novartis AG ADR | 5.00 | 3M | Healthcare |
Amgen Inc | 4.87 | 3M | Healthcare |
Cencora Inc | 4.32 | 2M | Healthcare |
McKesson Corp | 4.27 | 2M | Healthcare |
Johnson & Johnson | 3.99 | 2M | Healthcare |
United States